0001596771-17-000020.txt : 20170314
0001596771-17-000020.hdr.sgml : 20170314
20170314173307
ACCESSION NUMBER: 0001596771-17-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170310
FILED AS OF DATE: 20170314
DATE AS OF CHANGE: 20170314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gullans Steven R. Ph.D.
CENTRAL INDEX KEY: 0001571997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 17689093
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON ST., STE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-03-10
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001571997
Gullans Steven R. Ph.D.
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
1
0
0
0
Common Stock
2017-03-10
4
P
0
52798
9.47
A
858823
I
Held by Excel Venture Fund II, L.P.
Warrant to Purchase Common Stock
10.4
2017-03-10
4
P
0
39599
9.47
A
2017-03-10
2022-03-15
Common Stock
39599
39599
I
Held by Excel Venture Fund II, L.P.
The shares of common stock and warrants were purchased as part of a private placement pursuant to a Securities Purchase Agreement whereby the Issuer sold units consisting of one share of the Issuer's common stock and a warrant to purchase 0.75 shares of the Issuer's common stock at a per unit price of $9.47. The private placement is expected to close on March 15, 2017.
The reporting person, as the Manager of Excel Venture Fund II, L.P., beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Stephanie Swan, by Power of Attorney
2017-03-14